UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 274

Sortiert nach

Genetic variation in CYP3A43 explains racial difference in olanzapine clearance

Molecular psychiatry, 2011-06, Vol.16 (6), p.620-625

2011

Volltextzugriff (PDF)

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine

Pharmaceutics, 2023-04, Vol.15 (4), p.1139

2023

Volltextzugriff (PDF)

Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study

Schizophrenia bulletin, 2013-09, Vol.39 (5), p.993-998

2013

Volltextzugriff (PDF)

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Schizophrenia bulletin, 2013-05, Vol.39 (3), p.564-574

2013

Volltextzugriff (PDF)

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

Clinical and translational science, 2019-09, Vol.12 (5), p.519-528

2019

Volltextzugriff (PDF)

Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4424-4431

2010

Volltextzugriff (PDF)

exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity

Cancer chemotherapy and pharmacology, 2011-01, Vol.67 (1), p.93-101

2011

Volltextzugriff (PDF)

Predicting Age-Specific Dosing of Antipsychotics

Clinical pharmacology and therapeutics, 2009-10, Vol.86 (4), p.360-362

2009

Volltextzugriff (PDF)

Sex, Race, and Smoking Impact Olanzapine Exposure

Journal of clinical pharmacology, 2008-02, Vol.48 (2), p.157-165

2008

Volltextzugriff (PDF)

How Employees Respond to Personal Offense: The Effects of Blame Attribution, Victim Status, and Offender Status on Revenge and Reconciliation in the Workplace

Journal of applied psychology, 2001-02, Vol.86 (1), p.52-59

2001

Volltextzugriff (PDF)

Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials

Clinical and translational science, 2021-09, Vol.14 (5), p.1864-1874

2021

Volltextzugriff (PDF)

Modelling the progression of illicit substance use patterns from real‐world evidence

British journal of clinical pharmacology, 2024-03, Vol.90 (3), p.700-712

2024

Volltextzugriff (PDF)

Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients

The AAPS journal, 2020-03, Vol.22 (3), p.59, Article 59

2020

Volltextzugriff (PDF)

A model of anticholinergic activity of atypical antipsychotic medications

Schizophrenia research, 2006-12, Vol.88 (1), p.63-72

2006

Volltextzugriff (PDF)

Estimation of Renal Cell Carcinoma Treatment Effects From Disease Progression Modeling

Clinical pharmacology and therapeutics, 2013-04, Vol.93 (4), p.345-351

2013

Volltextzugriff (PDF)

Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study

Schizophrenia research, 2015-05, Vol.164 (1), p.149-154

2015

Volltextzugriff (PDF)

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

British journal of clinical pharmacology, 2008-11, Vol.66 (5), p.629-639

2008

Volltextzugriff (PDF)

Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability

CPT: pharmacometrics and systems pharmacology, 2024-06

2024

Volltextzugriff (PDF)

Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis

Pharmacopsychiatry, 2024-03, Vol.57 (2), p.53

2024

Volltextzugriff (PDF)

Evaluation of ChatGPT and Gemini large language models for pharmacometrics with NONMEM

Journal of pharmacokinetics and pharmacodynamics, 2024-06, Vol.51 (3), p.187-197

2024

Volltextzugriff (PDF)

Authors’ response to letter to editor

Journal of pharmacokinetics and pharmacodynamics, 2024-08, Vol.51 (4), p.305-305

2024

Volltextzugriff (PDF)

Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach

PloS one, 2013-09, Vol.8 (9), p.e73361-e73361

2013

Volltextzugriff (PDF)

A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance

The Journal of pharmacology and experimental therapeutics, 2022-12, Vol.383 (3), p.217

2022

Volltextzugriff (PDF)

The Critical Role of Clinical Pharmacology in Geriatric Psychopharmacology

Clinical pharmacology and therapeutics, 2009-01, Vol.85 (1), p.89-93

2009

Volltextzugriff (PDF)

Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study

Pharmacopsychiatry, 2015-11, Vol.48 (7), p.286

2015

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(234)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(157)
Humans
(136)
Male
(87)
Female
(82)
Pharmacology & Pharmacy
(73)
Biological And Medical Sciences
(69)
Adult
(66)
Middle Aged
(66)
Medical Sciences
(58)
Aged
(52)
Pharmacology. Drug Treatments
(37)
Animals
(35)
Psychiatry
(29)
Pharmacokinetics
(27)
Social Sciences
(27)
Schizophrenia - Drug Therapy
(23)
Adolescent
(22)
Models, Biological
(22)
Psychology. Psychoanalysis. Psychiatry
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genetic variation in CYP3A43 explains racial difference in olanzapine clearance

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine

Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients

exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity

Predicting Age-Specific Dosing of Antipsychotics

Sex, Race, and Smoking Impact Olanzapine Exposure

How Employees Respond to Personal Offense: The Effects of Blame Attribution, Victim Status, and Offender Status on Revenge and Reconciliation in the Workplace

Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials

Modelling the progression of illicit substance use patterns from real‐world evidence

Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients

A model of anticholinergic activity of atypical antipsychotic medications

Estimation of Renal Cell Carcinoma Treatment Effects From Disease Progression Modeling

Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability

Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis

Evaluation of ChatGPT and Gemini large language models for pharmacometrics with NONMEM

Authors’ response to letter to editor

Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach

A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance

The Critical Role of Clinical Pharmacology in Geriatric Psychopharmacology

Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study

Suchergebnisse filtern